Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

West Virginia · 2026 Regular Session · Bill

HB 4721: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 4721 is a bill introduced in the West Virginia House on January 22, 2026. According to its official title, it concerns: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration. Primary sponsor: Rick Hillenbrand (Republican). It lists 1 additional sponsor. Most recent recorded action (January 22, 2026): To House Health and Human Resources.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Republican 2

NameRolePartyChamberDistrict
Rick HillenbrandPrimary sponsorRepublicanHouse88
Evan WorrellCo-sponsorRepublicanHouse23

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. To House Health and Human Resources
  2. Introduced in House
  3. To Health and Human Resources then Judiciary
  4. Filed for introduction

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source